1
|
Shoji H, Hirai T, Shirakura T, et al: A
case of cysticercosis with multiple lesions in the brain and
femoral muscles. Kansenshogaku Zasshi. 87:608–612. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Rasamoelina-Andriamanivo H, Porphyre V and
Jambou R: Control of cysticercosis in Madagascar: beware of the
pitfalls. Trends Parasitol. 29:538–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Iacoangeli M, Moriconi E, Gladi M and
Scerrati M: Isolated cysticercosis of the cauda equina. J Neurosci
Rural Pract. 4(Suppl 1): S117–S119. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sciutto E, Fragoso G, Fleury A, et al:
Taenia solium disease in humans and pigs: an ancient parasitosis
disease rooted in developing countries and emerging as a major
health problem of global dimensions. Microbes Infect. 2:1875–1890.
2000. View Article : Google Scholar
|
5
|
Schantz PM, Cruz M, Sarti E and Pawlowski
Z: Potential eradicability of taeniasis and cysticercosis. Bull Pan
Am Health Organ. 27:397–403. 1993.PubMed/NCBI
|
6
|
García HH, Gonzalez AE, Evans CA and
Gilman RH; Cysticercosis Working Group in Peru: Taenia solium
cysticercosis. Lancet. 362:547–556. 2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Drew DR, Lightowlers M and Strugnell RA:
Vaccination with plasmid DNA expressing antigen from genomic or
cDNA gene forms induces equivalent humoral immune responses.
Vaccine. 18:692–702. 1999. View Article : Google Scholar : PubMed/NCBI
|
8
|
Solís CF, Ostoa-Saloma P, Lugo-Martínez
VH, Johnston SA and Laclette JP: vaccination against murine
cysticercosis by using a plasmid vector carrying Taenia solium
paramyosin. Infect Immun. 73:1895–1897. 2005. View Article : Google Scholar
|
9
|
Harrison GB, Heath DD, Dempster RP, et al:
Identification and cDNA cloning of two novel low molecular weight
host-protective antigens from Taenia ovis oncospheres. Int J
Parasitol. 26:195–204. 1996. View Article : Google Scholar : PubMed/NCBI
|
10
|
Lightowlers MW, Rolfe R and Gauci CG:
Taenia saginata: vaccination against cysticercosis in cattle with
recombinant oncosphere antigens. Exp Parasitol. 84:330–338. 1996.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Lightowlers MW, Flisser A, Gauci CG, Heath
DD, Jensen O and Rolfe R: Vaccination against cysticercosis and
hydatid disease. Parasitol Today. 16:191–196. 2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rosas G, Fragoso G, Garate T, et al:
Protective immunity against Taenia crassiceps murine cysticercosis
induced by DNA vaccination with a Taenia saginata tegument antigen.
Microbes Infect. 4:1417–1426. 2002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Martinez-Ocaña J, Romero-Valdovinos M, de
Kaminsky RG, Maravilla P and Flisser A: Immunolocalization of TSOL
18 and TSOL 45-1A, the successful protective peptides against
porcine cysticercosis, in Taenia solium oncospheres. Parasit
Vectors. 4:32011. View Article : Google Scholar
|
14
|
Flisser A, Gauci CG, Zoli A, et al:
Induction of protection against porcine cysticercosis by
vaccination with recombinant oncosphere antigens. Infect Immun.
72:5292–5297. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Cai X, Yuan G, Zheng Y, et al: Effective
production and purification of the glycosylated TSOL 18 antigen,
which is protective against pig cysticercosis. Infect Immun.
76:767–770. 2008. View Article : Google Scholar :
|
16
|
Zhou Z, Schnake P, Xiao L and Lal AA:
Enhanced expression of a recombinant malaria candidate vaccine in
Escherichia coli by codon optimization. Protein Expr Purif.
34:87–94. 2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Villalobos A, Ness JE, Gustafsson C, et
al: Gene Designer: a synthetic biology tool for constructing
artificial DNA segments. BMC Bioinformatics. 7:2852006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Sharp PM and Devine KM: Codon usage and
gene expression level in Dictyostelium discoideum: highly expressed
genes do ‘prefer’ optimal codons. Nucleic Acids Res. 17:5029–5039.
1989. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gao Z, Li Z, Zhang Y, et al: High-level
expression of the Penicillium notatum glucose oxidase gene in
Pichia pastoris using codon optimization. Biotechnol Lett.
34:507–514. 2012. View Article : Google Scholar
|
20
|
Lee MS, Hseu YC, Lai GH, et al: High yield
expression in a recombinant E. coli of a codon optimized chicken
anemia virus capsid protein VP1 useful for vaccine development.
Microb Cell Fact. 10:562011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Gustafsson C, Govindarajan S and Minshull
J: Codon bias and heterologous protein expression. Trends
Biotechnol. 22:346–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bulmer M: The selection-mutation-drift
theory of synonymous codon usage. Genetics. 129:897–907.
1991.PubMed/NCBI
|
23
|
Zheng JL, Jian GB and Guo XF: Codon
modification for improvement in prokaryotic expression of
glycoprotein gene in rabies virus. Chin J Zoonoses. 26:403–407.
2010.
|
24
|
Mani I, Singh V, Chaudhary DK, Somvanshi P
and Negi MP: Codon optimization of the major antigen encoding genes
of diverse strains of influenza a virus. Interdiscip Sci. 3:36–42.
2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Raab D, Graf M, Notka F, Schödl T and
Wagner R: The GeneOptimizer Algorithm: using a sliding window
approach to cope with the vast sequence space in multiparameter DNA
sequence optimization. Syst Synth Biol. 4:215–225. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wang JX, Peng YC and Yao YX:
Stage-specific expression of antigen encoded cDNA of cysticercus
cellulosae. Chin J Parasitol Parasit Dis. 2:89–93. 1996.
|
27
|
Greene RM, Hancock K, Wilkins PP and Tsang
VC: Taenia solium: molecular cloning and serologic evaluation of
14- and 18-kDa related, diagnostic antigens. J Parasitol.
86:1001–1007. 2000. View Article : Google Scholar : PubMed/NCBI
|
28
|
Hiszczyńska-Sawicka E, Li H, Xu JB, et al:
Comparison of immune response in sheep immunized with DNA vaccine
encoding Toxoplasma gondii GRA7 antigen in different adjuvant
formulations. Exp Parasitol. 124:365–372. 2010. View Article : Google Scholar
|
29
|
Yang TC: Study on the transfection
efficiency of the new cationic polymer transfection reagent:
Sofast. Xia men da xue xue bao. 43:572–577. 2004.
|
30
|
Khan KH: DNA vaccines: roles against
diseases. Germs. 3:26–35. 2013. View Article : Google Scholar
|
31
|
Vibanco-perez N, Jimenez L,
Mendoza-Hernandez G and Landa A: Characterization of a recombinant
mu-class glutathione stransferase from Taenia solium. Parasitol
Res. 88:394–404. 2002.
|
32
|
Rothel JS, Boyle DB, Both GW, et al:
Sequential nucleic acid and recombinant adenovirus vaccination
induces host-protective immune responses against Taenia ovis
infection in sheep. Parasite Immunol. 19:221–227. 1997. View Article : Google Scholar : PubMed/NCBI
|
33
|
Drew DR, Lightowlers M and Strugnell RA:
Humoral immune responses to DNA vaccines expressing secreted,
membrane bound and non-secreted forms of the Tania ovis 45W
antigen. Vaccine. 18:2522–2532. 2000. View Article : Google Scholar : PubMed/NCBI
|
34
|
Dong XX, Zhang C, Yang XW, et al:
Activities of treg cells stimulated by soluble adult worm antigen
and egg antigen of Schistosoma japonicum. Zhongguo Xue Xi Chong
Bing Fang Zhi Za Zhi. 25:146–150. 2013.PubMed/NCBI
|
35
|
Hwang J, Yi M, Zhang X, Xu Y, Jung JH and
Kim DK: Cytochalasin B induces apoptosis through the mitochondrial
apoptotic pathway in HeLa human cervical carcinoma cells. Oncol
Rep. 30:1929–1935. 2013.PubMed/NCBI
|
36
|
Weng SX, Sui MH, Chen S, et al:
Parthenolide inhibits proliferation of vascular smooth muscle cells
through induction of G0/G1 phase cell cycle arrest. Zhejiang Univ
Sci B. 10:528–535. 2009. View Article : Google Scholar
|